EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent—update 2013
A Heidenreich, PJ Bastian, J Bellmunt, M Bolla… - European urology, 2014 - Elsevier
… Author links open overlay panel Axel Heidenreich a , Patrick J. Bastian b , Joaquim Bellmunt
c , Michel Bolla d , Steven Joniau e , Theodor van der Kwast f , Malcolm Mason g , Vsevolod …
c , Michel Bolla d , Steven Joniau e , Theodor van der Kwast f , Malcolm Mason g , Vsevolod …
EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer
A Heidenreich, PJ Bastian, J Bellmunt, M Bolla… - European urology, 2014 - Elsevier
Objective To present a summary of the 2013 version of the European Association of Urology
(EAU) guidelines on the treatment of advanced, relapsing, and castration-resistant prostate …
(EAU) guidelines on the treatment of advanced, relapsing, and castration-resistant prostate …
Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium
…, GE Amiel, A Vazina, A Gupta, PJ Bastian… - The Journal of …, 2006 - auajournals.org
Purpose : We present the characteristics and outcomes of a large, contemporary, consecutive
series of patients treated with radical cystectomy and pelvic lymphadenectomy for …
series of patients treated with radical cystectomy and pelvic lymphadenectomy for …
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence
…, R Vorreuther, G Solleder, PJ Bastian, J Ellinger… - Cancer research, 2006 - AACR
Prostate cancer biology varies from locally confined tumors with low risk for relapse to
tumors with high risk for progression even after radical prostatectomy. Currently, there are no …
tumors with high risk for progression even after radical prostatectomy. Currently, there are no …
Prostate carcinogenesis and inflammation: emerging insights
GS Palapattu, S Sutcliffe, PJ Bastian, EA Platz… - …, 2005 - academic.oup.com
Prostate cancer remains a significant health concern for men throughout the world. Recently,
there has developed an expanding multidisciplinary body of literature suggesting a link …
there has developed an expanding multidisciplinary body of literature suggesting a link …
Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy
…, PI Karakiewicz, CG Rogers, A Vazina, PJ Bastian… - European urology, 2007 - Elsevier
OBJECTIVES: We compared clinical and pathologic staging in a large, contemporary,
consecutive series of patients who were treated with radical cystectomy and pelvic …
consecutive series of patients who were treated with radical cystectomy and pelvic …
Survival benefit of radical prostatectomy in lymph node–positive patients with prostate cancer
J Engel, PJ Bastian, H Baur, V Beer, C Chaussy… - European urology, 2010 - Elsevier
BACKGROUND: Positive lymph node (LN) status is considered a systemic disease state. In
prostate cancer, LN-positive diagnosis during pelvic LN dissection (PLND) potentially leads …
prostate cancer, LN-positive diagnosis during pelvic LN dissection (PLND) potentially leads …
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery
…, M Roupret, C Doehn, PJ Bastian, SC Muller, J Tostain… - European urology, 2010 - Elsevier
BACKGROUND: The occurrence of positive surgical margins (PSMs) after partial nephrectomy
(PN) is rare, and little is known about their natural history. OBJECTIVE: To identify …
(PN) is rare, and little is known about their natural history. OBJECTIVE: To identify …
[PDF][PDF] Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative …
…, GS Palapattu, A Vazina, PI Karakiewicz, PJ Bastian… - J Clin Oncol, 2005 - academia.edu
… J Clin Oncol 19:666-675, 2001 5. Millikan R, Dinney C, Swanson D, et al: Integrated
therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy …
therapy for locally advanced bladder cancer: Final report of a randomized trial of cystectomy …
Characteristics of insignificant clinical T1c prostate tumors: a contemporary analysis
BACKGROUND The authors examined the cases of men who had undergone radical
prostatectomy for low‐volume clinical T1c prostate carcinoma that was judged to be ‘insignificant’ …
prostatectomy for low‐volume clinical T1c prostate carcinoma that was judged to be ‘insignificant’ …